-
- Company
Exyte has completed the integration of Pharmaplan. As a result, the Pharmaplan brand and the acquired expertise in biopharma engineering have been fully incorporated into Exyte.
Exyte concludes integration of Pharmaplan: A-Z project execution of GMP facilities
Exyte announced the acquisition of Pharmaplan in September 2024 to establish a European market leader and deepen partnerships with the rapidly growing biotechnology and pharmaceutical sectors in Europe. Pharmaplan brings a network of locations and specialists across Europe, now operating within Exyt…








